HPRA Appoints New Chief Executive
25th January 2016
The Health Products Regulatory Authority (HPRA) announced that Lorraine Nolan has been appointed Chief Executive and will take up office with immediate effect.
Previously, she held the position of Director of Human Products Authorisation with the HPRA where she oversaw the evaluation and authorisation of medicines and medical devices for the Irish market.
Ms Nolan has extensive experience of the public health sector, the health product sector and the regulatory landscape. She will be responsible for the management of the HPRA whilst leading the organisation nationally and internationally in its ambition to protect and enhance human and animal health.
During her career to date, Ms Nolan has held a number of senior positions within the HPRA spanning the pharmaceutical assessment, products distribution and controlled drugs’ departments. Prior to joining the HPRA in 2001 she was Controlled Drugs Manager with the Department of Health and a Forensic Scientist with the Department of Justice Equality & Law Reform.
Lorraine holds a PhD in Chemistry and a Degree in Chemistry from Trinity College, Dublin. She has 20 years of technical and scientific experience attained through working in regulatory (including policy development), technical, senior management, industry and public service areas within the HPRA.
She is a member of the European Medicines Agency (EMA) Management Board; was previously an advisor to the UN’s International Narcotic Control Board and represented Ireland at European Committees in the Cosmetics and Drug Precursor areas.
